AbbVie Inc. — Director's Dealing 2020

Nov 12, 2020

SEC Form 4/A — Form 4/A

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2020-11-04

Reporting Person: SALEKI-GERHARDT AZITA (EVP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-04	Common Stock, $0.01 par value	M	4800	$24.2082	Acquired	118667	Direct
2020-11-04	Common Stock, $0.01 par value	S	4800	$93.61	Disposed	113867	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-04	Option (Right to buy)	$24.2082	M	4800	Disposed	2021-02-17	Common Stock (4800)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.01 par value	2027	Indirect
Common Stock, $0.01 par value	3873	Indirect

Footnotes

F1: Balance in AbbVie Savings program as of November 10, 2020.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.

F3: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.